The Colorado firm is expanding its partnerships, outreach efforts, technology applications, and sales force for its oncology screening and monitoring test business.
INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million ...